Skip to main content
Log in

The Minnesota diabetes complications clinical trial the first three years

  • Preliminary Communication
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

A prospective and randomized clinical trial of an inception cohort of diabetic kidney recipients to test the hypothesis that maximized metabolic control of diabetes prevents or delays diabetic nephropathy in the renal allografts was initiated approximately three years ago. Notwithstanding the fact that all our diabetic patients were on prednisone and therefore metabolically unstable, we achieved and maintained a clear difference between the standard control (group A) and the maximized control patients (group B). At 13 months of study, the mean fasting blood glucose mg% (A: 242±22, B: 130±9, p<0.001), nonfasting blood glucose (A: 276±40, B: 135±10, p<0.001), 24 hour urine glucose (A: 85±16, B: 5±1, p<0.001), and glycosylated hemoglobin % (A: 13±0.9, B: 10±0.8, p<0.01) were all clearly and statistically significantly higher for the group A patients. These results show the feasibility of such a trial using the tools available today to treat diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barbosa J., Menth L., Eaton J., Sutherland D., Freier E., Najarian J.: Long-term, ambulatory subcutaneous insulin infusion vs. multiple daily injections in brittle diabetics — Diabetes Care4, 269, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Barbosa J., Menth L., Schumacher G., Johnson S., Najarian J.: Feasibility of blood glucose self-monitoring in unstable insulin-dependent diabetes — Diabetes Care3, 155, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Cahill G., Etzwiler D., Freinkel N.: ‘Control’ and diabetes — New Engl. J. Med.294, 1004, 1976.

    Article  PubMed  Google Scholar 

  4. Ingelfinger F.: Debates on diabetes — New Engl. J. Med.296, 1228, 1977.

    Article  PubMed  CAS  Google Scholar 

  5. Mauer S. M., Barbosa J., Vernier R. L., Najarian J. S., Goetz F. C.: Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus — New Engl. J. Med.295, 916, 1976.

    Article  PubMed  CAS  Google Scholar 

  6. Ross H., Rifkin H.: Metabolic control and vascular disease in diabetes mellitus. In:Podolsky S. (Ed.): Clinical diabetes: modern management. Appleton-Century-Crofts, New York, 1980; p. 565.

    Google Scholar 

  7. Spierstein M.D., Foster D. W., Knowles H. C., Levine R., Madison L. L., Roth J.: Control of blood glucose and diabetic vascular disease — New Engl. J. Med.296, 1060, 1977.

    Article  Google Scholar 

  8. Svendsen P. Aa., Christiansen J. S., Welinder B., Nerup J.: Fast glycosylation of hemoglobin — Lanceti, 603, 1979.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barbosa, J., Connett, J., Fryd, D. et al. The Minnesota diabetes complications clinical trial the first three years. Acta diabet. lat 20, 164–171 (1983). https://doi.org/10.1007/BF02624917

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02624917

Key-words

Navigation